NewLimit, a startup that aims to increase how long people can live a healthy life by genetically programming their cells, has ...

NewLimit was founded to develop medicines that add healthy years to each human life. Initially, we thought it would take many ...

NewLimit’s Series B raise adds fuel to Silicon Valley’s growing obsession with anti-aging science and biohacking immortality.

On Tuesday, that startup—NewLimit—raised a $130 million Series B round led by venture capital giant Kleiner Perkins with contributions from new and existing investors including Khosla Ventures ...

Welcome to Startups Weekly — your weekly recap of everything you can’t miss from the world of startups. Want it in your inbox ...

No limit: NewLimit, the longevity startup founded by Coinbase CEO Brian Armstrong, raised a $130 million Series B led by Kleiner Perkins to develop age-reversing therapies.

NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...